Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRCKB DiscoveRx kinase panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
MRCKbeta(h) Kinase panel
Inhibition of MRCKbeta (unknown origin) at 1 uM
SummaryPubMed CitationRelated BioAssays by Target
Kinase Assay from US Patent US11447505: "Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer"
Assay data:225 Active, 76 Activity ≤ 1 nM, 225 Activity ≤ 1 µM, 225 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Binding Assay from Article 10.1074/jbc.M707463200: "Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta."
Assay data:5 Active, 2 Activity ≤ 1 nM, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
KinomeScan assay: inhibition of MRCKB
Assay data:108 Tested
MRCKbeta(h) Eurofins kinase panel
CDC42BPB ProQinase selectivity panel
CDC42 BPB (MRCKB) Kinase screen
CDC42 BPB Invitrogen selectivity data (BI)
MRCKbeta (h) Eurofins Kinase panel
MRCKbeta (h) Millipore kinase activity assay
CDC42 BPB (MRCKB) SelectScreen Kinase panel (LifeTechnologies)
MRCKbeta(h) Millipore kinase panel
CDC42 BPB Invitrogen Lab (UK) kinase screen (BI)
Inhibition of CDC42BPB (unknown origin) assessed as residual activity measured at 1 uM
Assay data:3 Tested
Inhibition of human MRCKB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of DNA-tagged human MRCKB assessed as percent of control at 50000 nM by qPCR analysis relative to control
Inhibition of human MRCKB assessed as percent of control at 1000 nM by KINOMEscan assay relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on